| Literature DB >> 27347436 |
K P Vatcheva1, M Lee2, J B McCormick1, M H Rahbar3.
Abstract
OBJECTIVE: To demonstrate the adverse impact of ignoring statistical interactions in regression models used in epidemiologic studies. STUDY DESIGN ANDEntities:
Keywords: Cox proportional hazards model; Effect modification; Regression analysis; Simulation; Statistical interaction; Type 2 diabetes
Year: 2015 PMID: 27347436 PMCID: PMC4918637 DOI: 10.4172/2161-1165.1000216
Source DB: PubMed Journal: Epidemiology (Sunnyvale)
Cox proportional hazards regression models used for different scenarios of the simulation study.
| Scenario | Cox proportional hazards regression model |
|---|---|
| 1 | h(t|x)=h0(t) exp (2x1+x2) |
| 2 | h(t|x)=h0(t) exp (2x1+x2+0.5x1x2) |
| 3 | h(t|x)=h0(t) exp (2x1+x2+x1x2) |
| 4 | h(t|x)=h0(t) exp (2x1+x2+1.5x1x2) |
The values of the regression coefficients were arbitrarily set for simulations.
Findings from multivariable Cox proportional hazards regression model fitted using generated data in scenario 1.
| Parameter estimates | Correct Model | Misspecified Model |
|---|---|---|
| Estimated coefficient of X1 ± SE | 2.01 ± 0.09 | 2.01 ± 0.11 |
| %bias in estimated coefficient of X1 | 0.50% | 0.50% |
| MSE | 0.01 | 0.01 |
| Estimated coefficient of X2 ± SE | 1 ± 0.12 | 0.98 ± 0.85 |
| %bias in estimated coefficient | 0.00% | −2.00% |
| MSE | 0.02 | 0.72 |
| Estimated coefficient of X1 | - | 0.003 ± 0.11 |
Correct model is model with no interaction term X1*X2 included;
Misspecified model is the model that include interaction term X1*X2 in addition to X1 and X2 main effects;
Mean squared error is defined as the sum of the variance of the estimator and the squared bias.
Findings from multivariable Cox proportional hazards regression models fitted using generated data in scenarios 2, 3 and 4.
| Parameter estimates | Data generated with b3=0.5 (Model 2) | Data generated with b3=1.0 (Model 3) | Data generated with b3=1.5 (Model 4) | |||
|---|---|---|---|---|---|---|
| Misspecified Model | Correct Model | Misspecified Model | Correct Model | Misspecified Model | Correct Model | |
| Estimated coefficient of X1 ± SE | 2.26 ± 0.09 | 2.01 ± 0.11 | 2.42 ± 0.09 | 2.01 ± 0.11 | 2.52 ± 0.1 | 2.01 ± 0.12 |
| %bias in estimated coefficient | 13.00% | 0.50% | 21.00% | 0.50% | 26.00% | 0.50% |
| MSE | 0.08 | 0.01 | 0.19 | 0.01 | 0.29 | 0.01 |
| Estimated coefficient of X2 ± SE | 4.52 ± 0.21 | 1 ± 0.83 | 7.51 ± 0.3 | 1.04 ± 0.91 | 9.94 ± 0.39 | 1.03 ± 1.01 |
| %bias in estimated coefficient | 352.00% | 0.00% | 651.00% | 4.00% | 894.00% | 3.00% |
| MSE | 12.43 | 0.7 | 42.49 | 0.85 | 80.18 | 1.03 |
| Estimated coefficient of X1 | - | 0.5 ± 0.12 | - | 1 ± 0.14 | - | 1.5 ± 0.16 |
| %bias in estimated coefficient | 0.00% | 0.00% | 0.00% | |||
| MSE | 0.01 | 0.02 | 0.03 | |||
Misspecified model is the model with no interaction term X1*X2 included
Correct model is the model with interaction term X1*X2 as well as the main effects of X1 and X2
Mean squared error is defined as the sum of the variance of the estimator and the squared bias
Findings (SI units) from interactive multivariable Cox proportional hazards regression models of time to first type 2 diabetes using Cameron County Hispanic Cohort data, 2003–2014.
| Variables | Unadjusted models | Adjusted models |
|---|---|---|
| HR (95% CI) | HR (95% CI) | |
| Models with total WBC counts ×109/L: Hazard ratio for WBC by the levels of the interacting variable BMI | ||
| WBC in BMI≥35 | 1.29 (1.07–1.55) | 1.49 (1.20–1.85) |
| WBC in BMI<35 | 1.09 (0.97–1.23) | 1.09 (0.97–1.85) |
| Models with Lymphocytes ×109/L: Hazard ratio for Lymphocytes by the levels of the interacting variable BMI | ||
| Lymphocytes in BMI≥35 | 2.60 (1.49–4.53) | 2.95 (1.57–5.52) |
| Lymphocytes in BMI<35 | 1.45 (0.98–2.12) | 1.43 (0.98–2.09) |
| Models with Monocytes ×109/L: Hazard ratio for Monocytes by the levels of the interacting variable BMI | ||
| Monocytes in BMI≥35 | 3.36 (0.46–24.64) | 3.71 (0.44–31.19) |
| Monocytes in BMI<35 | 1.88 (0.41–8.68) | 1.73 (0.40–7.42) |
| Models with Granulocytes ×109/L: Hazard ratio for Granulocytes by the levels of the interacting variable BMI | ||
| Granulocytes in BMI≥35 | 1.26 (1.00–1.60) | 1.49 (1.14–1.94) |
| Granulocytes in BMI<35 | 1.06 (0.92–1.22) | 1.07 (0.92–1.23) |
| Models with Granulocytes ×109/L and Lymphocytes ×109/L: Hazard ratio for Granulocytes by the levels of the interacting variable BMI | ||
| Granulocytes in BMI≥35 | 1.2 (0.95–1.52) | 1.46 (1.19–1.92) |
| Granulocytes in BMI<35 | 1.02 (0.88–1.20) | 1.02 (0.86–1.20) |
Models adjusted for age, gender, smoking, and triglycerides and stratified by family history of diabetes and pre-diabetes status by including strata statement in SAS Proc Phreg.
Findings (SI units) from multivariable Cox proportional hazards regression models* for time to first type 2 diabetes among participants in BMI stratified Cameron County Hispanic Cohort, 2003–2014.
| Variables | BMI groups | |
|---|---|---|
| BMI<35 | BMI ≥35 | |
| HR (95% CI) | HR (95% CI) | |
| Models with total WBC counts ×109/L | ||
| WBC | 1.10 (0.97, 1.24) | 1.47 (1.14, 1.89) |
| Models with Lymphocytes ×109/L | ||
| Lymphocytes | 1.43 (0.98, 2.1) | 3.25 (1.58, 6.7) |
| Models with Monocytes ×109/L | ||
| Monocytes | 1.80 (0.43, 7.55) | 3.13 (0.38, 26) |
| Models with Granulocytes ×109/L | ||
| Granulocytes | 1.07 (0.92, 1.24) | 1.42 (1.06, 1.9) |
| Models with Granulocytes ×109/L and Lymphocytes ×109/L | ||
| Granulocytes | 1.04 (0.89, 1.22) | 1.36 (1.002, 1.83) |
Models adjusted for age, gender, smoking, and triglycerides and stratified by family history of diabetes and pre-diabetes status by including strata statement in SAS Proc Phreg.
Figure 1Estimated Adjusted Hazard Ratios for total WBC counts in relation to time to progression to type 2 diabetes in Mexican Americans by the levels of BMI. (a) Excluding the interaction term between BMI and WBC. (b) Including the interaction term between BMI and WBC.
Figure 2Estimated Adjusted Hazard Ratios in relation to time to progression to type 2 diabetes by the levels of BMI for (a) Granulocytes, (b) Lymphocytes and (c) Monocytes.